Your browser doesn't support javascript.
loading
Amphoteric Mannan as an Immune Response Modifier. New Model Immunobiologically Active Candida albicans Mannan-Based Formula.
Paulovicová, Ema; Paulovicová, Lucia; Cízová, Alzbeta; Mecárová, Jana; Vrzonová, Romana; Farkas, Pavol; Bystrický, Slavomír.
Afiliação
  • Paulovicová E; Institute of Chemistry, Department of Immunochemistry of Glycoconjugates, Immunology & Cell Culture Labs, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Paulovicová L; Institute of Chemistry, Department of Immunochemistry of Glycoconjugates, Immunology & Cell Culture Labs, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Cízová A; Institute of Chemistry, Department of Immunochemistry of Glycoconjugates, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Mecárová J; Institute of Chemistry, Department of Immunochemistry of Glycoconjugates, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Vrzonová R; Institute of Chemistry, Department of Immunochemistry of Glycoconjugates, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Farkas P; Institute of Chemistry, Department of Immunochemistry of Glycoconjugates, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Bystrický S; Institute of Chemistry, Department of Immunochemistry of Glycoconjugates, Slovak Academy of Sciences, Bratislava, Slovakia.
Immunol Invest ; 52(4): 415-438, 2023 Nov.
Article em En | MEDLINE | ID: mdl-36975044
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida albicans / Mananas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Immunol Invest Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida albicans / Mananas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Immunol Invest Ano de publicação: 2023 Tipo de documento: Article